WEPOX 4000

Wepox 4000 Injection contains epoetin alfa, a synthetic form of erythropoietin used to treat anemia caused by chronic kidney disease, cancer chemotherapy, or certain medical conditions. It works by stimulating the bone marrow to produce more red blood cells, helping improve oxygen levels in the body and reducing symptoms such as fatigue, weakness, and shortness of breath.

This injection is commonly prescribed for patients undergoing dialysis or cancer therapy or those with severe anemia where red blood cell production is low. It is administered under medical supervision, usually as a subcutaneous or intravenous injection, with dosage adjusted based on hemoglobin levels and patient response. Regular monitoring is important to ensure safe treatment and avoid complications such as high blood pressure or blood clots.

For pharmaceutical distributors, hospitals, and healthcare providers, Wepox 4000 Injection is supplied in secure, quality-tested packaging suitable for global export. It is widely used in nephrology centers, oncology clinics, and critical care settings requiring reliable anemia management medicines. Always use under medical guidance and follow prescribed dosage instructions for best therapeutic outcomes.

Product Features

• Effective treatment for anemia due to kidney disease or chemotherapy
• Stimulates natural red blood cell production
• Administered under medical supervision
• Quality-assured packaging for global distribution
• Suitable for hospitals, dialysis centers, and clinics

How It Helps

• Increases red blood cell count
• Improves oxygen supply in the body
• Reduces fatigue and weakness
• Supports recovery during chronic illness treatment